2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P10929
    Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH
    		99.09%
    Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a side chain of tirzepatide.
    Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH
  • HY-N14823
    Demethylmacrocin
    Demethylmacrocin is a key intermediate in the biosynthetic pathway of Tylosin (HY-B0519A). Demethylmacrocin can be efficiently converted into tylosin through specific sequential oxidation and methylation reactions.
    Demethylmacrocin
  • HY-20128S
    Piperazin-2-one-d6
    Piperazin-2-one-d6 is the deuterium labeled Piperazin-2-one (HY-20128). Piperazin-2-one is a piperazine ring derivative containing amide and ester carbonyl groups. As an important intermediate, Piperazin-2-one can be used for the synthesis of various active compounds.
    Piperazin-2-one-d<sub>6</sub>
  • HY-48626
    L2H2-6OTD intermediate-3
    L2H2-6OTD intermediate-3 is an intermediate for the synthesis of L2H2-6OTD (HY-148200) and can be used for ADC preparation. L2H2-6OTD, a telomestatin analog with telomerase inhibitory activity (IC50: 15 nM).
    L2H2-6OTD intermediate-3
  • HY-114627
    Valone
    Valone is an intermediate in the preparation of diorganotin(IV) complexes.
    Valone
  • HY-W701476
    Ethyl phenylglyoxylate-d5
    Ethyl phenylglyoxylate-d5 (Ethyl benzoylformate-d5; Phenylglyoxylic acid ethyl ester-d5) is the deuterium labeled Ethyl phenylglyoxylate (HY-W016618). Ethyl phenylglyoxylate (Ethyl benzoylformate), the ethyl ester of phenylglyoxylic acid, is used as a synthetic reagent. Ethyl phenylglyoxylate is also a poor substrate but a potent inhibitor of chicken liver carboxylesterase. Additionally, Ethyl phenylglyoxylate exhibits photoreactivity, where its excited triplet carbonyl can initiate intermolecular hydrogen abstraction, radical coupling and cross-linking reactions.
    Ethyl phenylglyoxylate-d<sub>5</sub>
  • HY-W012389
    5-Bromo-1,2-difluoro-3-methoxybenzene
    5-Bromo-1,2-difluoro-3-methoxybenzene (5-Bromo-2,3-difluoroanisole) is a drug synthesis intermediate that can be used to synthesize a ligand of glucocorticoid receptor (GR).
    5-Bromo-1,2-difluoro-3-methoxybenzene
  • HY-B1657
    Fosphenytoin
    Fosphenytoin is a phosphate ester proagent developed as an alternative to intravenous phenytoin for acute intervention of seizures. Fosphenytoin has advantages including more convenient and rapid intravenous administration, availability for intramuscular injection, and low potential for adverse local reactions at injection sites.
    Fosphenytoin
  • HY-34487R
    1,3-Dimethoxybenzene (Standard)
    1,3-Dimethoxybenzene (Standard) is the analytical standard of 1,3-Dimethoxybenzene. This product is intended for research and analytical applications. 1,3-Dimethoxybenzene belongs to the class of organic compounds known as dimethoxybenzenes. 1,3-Dimethoxybenzene is an intermediate in synthesis of organic compounds[1].
    1,3-Dimethoxybenzene (Standard)
  • HY-169852
    Doxapram intermediate-1
    Doxapram intermediate-1 (Compound II) is a pyrrolidinone derivative with pronounced central nervous system (CXS) and respiratory stimulation in the dog usually accompanied by varying degrees of pressor activity.
    Doxapram intermediate-1
  • HY-34588R
    D-4-Hydroxyphenylglycine (Standard)
    D-4-Hydroxyphenylglycine (Standard) is the analytical standard of D-4-Hydroxyphenylglycine. This product is intended for research and analytical applications. D-4-Hydroxyphenylglycine (D-(-)-4-Hydroxyphenylglycine) is one of the most important raw materials used in the production of semisynthetic β-lactam antibiotics, such as Amoxicillin (HY-B0467A) and Cefadroxil (HY-B1190).
    D-4-Hydroxyphenylglycine (Standard)
  • HY-177146
    Paclitaxel-MVCP
    Paclitaxel-MVCP (MC-Val-Cit-PAB-Paclitaxel) (Compound R-8) is a drug-linker conjugate, and can be used for synthesis of Paclitaxel-nucleolin aptamer conjugate.
    Paclitaxel-MVCP
  • HY-128753S7
    D-Lyxose-d-1
    D-Lyxose-d-1 is the deuterium labeled D-Lyxose. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose.
    D-Lyxose-d-1
  • HY-170749
    DFO-BCN
    DFO-BCN is a drug intermediate, that can be used for synthesis of PET/CT imaging agent DFO-CPC634 through click chemistry.
    DFO-BCN
  • HY-W009948R
    Vanillin acetate (Standard)
    Vanillin acetate (Standard) is the analytical standard of Vanillin acetate. This product is intended for research and analytical applications. Vanillin acetate is a phenol ester that can be synthesized from vanillin by treatment with acetic anhydride[1].
    Vanillin acetate (Standard)
  • HY-W030771
    ((4-(tert-Butyl)phenyl)sulfonyl)methionine
    ((4-(tert-Butyl)phenyl)sulfonyl)methionine can be used for peptide synthesis.
    ((4-(tert-Butyl)phenyl)sulfonyl)methionine
  • HY-W006371S
    (2-Aminoethyl)phosphonic acid-d4
    (2-Aminoethyl)phosphonic acid-d4 is the deuterium labeled (2-Aminoethyl)phosphonic acid (HY-W006371). (2-Aminoethyl)phosphonic acid is an endogenous metabolite and amino acid analog. (2-Aminoethyl)phosphonic acid can be used for the synthesis of biological macromolecules and the preparation of hydrogels.
    (2-Aminoethyl)phosphonic acid-d<sub>4</sub>
  • HY-128753S5
    D-Lyxose-13C-4
    D-Lyxose-13C-4 is the 13C labeled D-Lyxose. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose.
    D-Lyxose-<sup>13</sup>C-4
  • HY-139551
    Guraxetan
    Guraxetan can be used for the synthesis of antineoplastic lutetium (177Lu) zadavotide Guraxetan.
    Guraxetan
  • HY-158575
    all-cis-14,17,20,23,26,29-Dotriacontahexaenol
    all-cis-14,17,20,23,26,29-Dotriacontahexaenol (14(Z),17(Z),20(Z),23(Z),26(Z),29(Z)-Dotriacontahexaenol) is a long-chain fatty alcohol. It is an intermediate in the synthesis of the very long-chain PUFA all-cis-14,17,20,23,26,29-dotriacontahexaenoic acid.
    all-cis-14,17,20,23,26,29-Dotriacontahexaenol